Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Flavin adenine dinucleotide (FAD) is a redox-active coenzyme derived from riboflavin (vitamin B2). It acts as a critical electron carrier in cellular metabolism, particularly within mitochondrial oxidative phosphorylation and the citric acid cycle, where it shuttles electrons between metabolic intermediates and the electron transport chain[1][3][4][6][7][10]. FAD is essential for the function of a broad array of flavoproteins and enzymes, including oxidoreductases, dehydrogenases, and monooxygenases, all of which mediate key oxidative and reductive biochemical reactions[4][6][7]. As a coenzyme, FAD is vital for energy production, amino acid metabolism, fatty acid oxidation, and DNA repair in living systems[1][3][4][6][7][10]. Human cells synthesize FAD from dietary riboflavin via the sequential activities of riboflavin kinase (producing FMN) and FAD synthase[1][5][6]. Disruption of FAD biosynthesis or riboflavin deficiency leads to impaired energy metabolism and can contribute to neurological, metabolic, or mitochondrial disorders[1][4]. Note: Flavin adenine dinucleotide is a metabolite/cofactor, not a conventional therapeutic target such as a receptor, enzyme, or transporter[1][4][10]. Thus, while it is essential for the function of many drug targets, it is not itself directly targeted by therapeutic drugs; instead, it is required for the proper activity of flavoprotein enzymes that are sometimes drug targets[3][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Flavin adenine dinucleotide (FAD).